<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="125878">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01650974</url>
  </required_header>
  <id_info>
    <org_study_id>E-1205-154-002</org_study_id>
    <secondary_id>H-1206-074-414</secondary_id>
    <nct_id>NCT01650974</nct_id>
  </id_info>
  <brief_title>High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy</brief_title>
  <acronym>HFNOT</acronym>
  <official_title>High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy: A Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy and safety of nasal high flow oxygen
      therapy during diagnostic bronchoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypoxemia is frequently seen during diagnostic bronchoscopy. Nasal prong or other existing
      oxygen supply methods are often difficult to maintain adequate oxygenation during
      bronchoscopy. In particular, bronchoscopy to patients already showing hypoxemia can be
      dangerous even though applying conventional oxygen therapy. Thus, we want to elucidate the
      usefulness of nasal high flow oxygen therapy to hypoxemic patients undergoing diagnostic
      bronchoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Success rate of bronchoscopy</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Success is defined as completion of planned diagnostic procedure with the oxygen saturation or partial pressure of oxygen in arterial blood was similar to the level of before the procedure.
Failure is defined as incompletion of planned diagnostic procedure due to sustained hypoxemia or else.
Furthermore failure is defined as hypoxemia(SaO2 &lt;88%) was developed more than 2 times even though planned procedure was completed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>frequency and duration of hypoxia</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>frequency and duration of hypoxia(oxygen saturation &lt;88%) during procedure or after procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>switch to oxygen therapy method</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Increase oxygen apply or change of oxygen therapy method to high flow system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of respiratory symptoms</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>scoring of dyspnea symptoms, patients's comfort.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">114</enrollment>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>conventional oxygen therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>conventional nasal prong with FiO2 ~0.4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNOT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high flow nasal oxygen therapy with starting FiO2 0.4 and Flow 40 L/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham-HFNOT</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>same device with FiO2 ~0.4, NO high flow</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HFNOT</intervention_name>
    <description>high flow nasal oxygen therapy</description>
    <arm_group_label>HFNOT</arm_group_label>
    <arm_group_label>sham-HFNOT</arm_group_label>
    <other_name>high flow nasal oxygen therapy(OPTIFLOW)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: 1 or 2 or 3

        1. PaO2 &lt; 60 mmHg on ABGA or SpO2 &lt; 90 % in room air AND SpO2 ≥ 95% or PaO2 ≥ 75mmHg in
        low flow oxygen therapy 3. Planning to diagnostic bronchoscopic procedure(e.g. bronchial
        washing, BAL, bronchoscopic biopsy, EBUS-TBNA etc.)

        Exclusion Criteria:

          1. patients who did not agree to provide information

          2. patients requiring for emergent intubation

          3. patients can not wear or be already applied high flow nasal oxygen therapy

          4. patients with unstable vital sign(e.g. severe hypotension, uncontrolled arrhythmia,
             etc.)

          5. patients with multiple organ failures

          6. patients with plan to therapeutic bronchoscopic procedure(e.g. intervention)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young-Jae Cho, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young-Jae Cho, MD</last_name>
    <phone>82-10-9925-7058</phone>
    <email>lungdrcho@snubh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jisoo Park, MD</last_name>
    <phone>82-10-6533-0452</phone>
    <email>subac1@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Jae Cho</last_name>
      <phone>82-10-9925-7058</phone>
      <email>lungdrcho@snubh.org</email>
    </contact>
    <contact_backup>
      <last_name>Jisoo Park</last_name>
      <phone>82-10-6533-0452</phone>
      <email>subac1@naver.com</email>
    </contact_backup>
    <investigator>
      <last_name>Young-Jae Cho, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 11, 2014</lastchanged_date>
  <firstreceived_date>July 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Young-Jae Cho</investigator_full_name>
    <investigator_title>Seoul National University Bundang Hospital</investigator_title>
  </responsible_party>
  <keyword>high flow nasal oxygen therapy</keyword>
  <keyword>diagnostic bronchoscopy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
